Wikisage, the free encyclopedia of the second generation, is digital heritage
Levetiracetam: Difference between revisions
Jump to navigation
Jump to search
(→Links: File:Wikidata-logo-en.svg.png) |
(→Links: wlink) |
||
| Line 13: | Line 13: | ||
Jackson J.-L. et al.2015 | Jackson J.-L. et al.2015 | ||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501738/ A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache] | *[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501738/ A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache] | ||
[[File:Wikidata-logo-en.svg.png|32px]] | [[File:Wikidata-logo-en.svg.png|32px]][https://www.wikidata.org/wiki/Q417227 Q417227] | ||
[[Category:Anticonvulsants]] | [[Category:Anticonvulsants]] | ||
Revision as of 03:15, 6 October 2015
(S)-2-(2-Oxopyrrolidin-1-yl)butanamide is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.
Extended release
Links
Trinka E., et al 2015
- Pharmacotherapy for Status Epilepticus Drugs 75:1499
Safraski J.-P.2015
Jackson J.-L. et al.2015
